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Abstract
Background and Purpose: Port-site metastasis (PSM) is a rare complication of laparoscopic intervention in
urologic malignancies. Of the greater than 50 reported cases of PSM in the urologic oncology literature, only 9
have occurred after surgery for renal-cell carcinoma (RCC). We report a 10th instance of RCC metastasis—in this
case to the camera-port site after robot-assisted partial nephrectomy (RAPN). To our knowledge, this case is the
first reported PSM of RCC after RAPN.
Patient and Methods: A 68-year-old man underwent an uncomplicated right RAPN for a 4-cm right renal mass
(stage T1aN0M0). Five months later, he was found to have metastatic disease with an isolated peritoneal re-
currence at the camera-port site. Biopsy of the lesion confirmed RCC, and the lesion was surgically resected. A
comprehensive MEDLINE search for all published studies of port-site recurrences after laparoscopic renal
surgery for RCC was performed.
Results: Nine cases of PSM after successful laparoscopic radical or partial nephrectomy for locally confined RCC
have been reported. Proposed etiologic factors for port-site recurrence include biologic aggressiveness of the
tumor, patient immunosuppression, local wound factors, and technique-related factors. We report an unusual
case of PSM to a camera port that was not used for specimen manipulation or extraction.
Conclusion: PSM after laparoscopic renal surgery for RCC is a rare occurrence. Our case, in which PSM occurred
without specimen bag rupture or extraction through the port in question, highlights the importance of local and
systemic factors in contributing to PSM occurrence. We also demonstrate that when PSM is the only site of
disease recurrence, it can be successfully managed with minimally invasive surgical resection.
Introduction
Since the first successful laparoscopic nephrectomyin 1991,1 minimally invasive approaches have been in-
creasingly used in tumor resection and lymph node dissection
for urologic cancers. This approach has multiple advantages,
including decreased length of hospitalization, decreased pain,
faster recovery, and improved cosmesis.2 Laparoscopic sur-
gery has equivalent oncologic outcomes to open procedures;
however, port-site metastasss (PSM) is rare, troubling, and
often unexplained occurrences.3–5
PSM has been reported with multiple malignancies, most
commonly in the gynecologic and surgical literature.6–8 The
first known occurrence of PSM after a urologic procedure was
in 1994, when Stolla and associates9 reported a case of sub-
cutaneous metastasis of bladder transitional-cell carcinoma
(TCC) after laparoscopic pelvic lymph node dissection. Since
then, more than 50 PSMs have been reported in the setting of
urologic surgery.10
PSM after laparoscopic extirpative surgery for renal-cell
carcinoma (RCC) is extremely rare. An international review of
2604 cases by Micali and colleagues8 in 2004 identified no
instances of port-site recurrence. We performed a compre-
hensive MEDLINE search for published reports of PSM after
laparoscopic nephrectomy or partial nephrectomy for RCC. In
total, nine cases of PSM from RCC were identified.11–19
We report a 10th case of RCC metastasis to a port site, and




A 68-year-old man was incidentally discovered to have a 4-
cm right renal mass (Fig. 1) with a nephrometry score of 10a.
There was no radiographic evidence of lymph node involve-
ment or distant metastasis. He successfully underwent RAPN
in October 2011. During the resection, the mass was not
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obviously violated. The specimen was placed into an en-
trapment sack and extracted intact through the assistant port
site. The extraction site was reapproximated at the fascia with
an 0 polyglactin suture. The subcutaneous tissue at all sites
was irrigated and the skin edges reapproximated with a sta-
pling device. Pathologic examination revealed a 3.9 cm T1a
clear-cell, Fuhrman grade 3/4 RCC with negative margins
results (Fig. 2). Five months later, in March 2012, routine fol-
low-up CT revealed a 1.7 cm mass located on the abdominal
wall (Fig. 3) at the camera port site used during the initial
resection. Of note, this site was not used for specimen ex-
traction. The patient was otherwise free of disease recurrence
and completely asymptomatic. Ultrasound-guided biopsy of
the abdominal wall mass showed metastatic RCC that stained
strongly for RCC-immunoperoxidase (Fig. 4). In the absence
of other metastatic disease, the patient was scheduled for re-
section of the PSM.
With the patient in the left lateral decubitus position using a
retroperitoneal approach, the peritoneum was entered after the
retroperitoneal space was developed. The mass was well vi-
sualized (Fig. 5A) and was circumferentially excised with wide
margins (Fig. 5B). The mass was then placed in an entrapment
sack. The posterior rectus fascia was closed with 2-0 polyglactin
suture, which was reinforced with Weck Hem-o-lok clips
(Teleflex, Research Triangle Park, NC). Hemostasis was en-
sured after the insufflation pressure was decreased to 5 mm
Hg, the specimen was extracted, and the port sites were closed.
Blood loss was minimal, and the patient was discharged home
on postoperative day one. Pathologic examination of the PSM
demonstrated a 3.4-cm granular variant clear-cell RCC with
negative margins results. A follow-up CT scan 3 months later
did not reveal new metastatic disease or locally recurrent dis-
ease in the kidney or at the camera-port site (Fig. 6).
Discussion
The risk of loco-regional disease dissemination and recur-
rence after laparoscopic surgery for abdominal and pelvic
malignancies is well documented in the gynecologic and
surgical oncology literature, with an incidence ranging up to
5% for gynecologic malignancies and 4% for colorectal cancer.
In one report, port-site metastasis developed in 70 (17.1%) of
409 patients with incidental gallbladder cancers discovered
during laparoscopic cholecystectomy, 70% of which occurred
in the port used for extraction of the specimen.
Laparoscopy been applied extensively to manage malig-
nancies in urology and, in recent years, several reports of PSM
and tumor seeding have been published in the urologic lit-
erature. The reported incidence of port-site seeding in the
literature is variable, because some studies suggest an inci-
dence as high as 21%.20 Most authors agree, however, that the
rate of port-site seeding is rare (< 1%),21 and some report that
these rates are similar to rates of wound seeding noted in open
procedures.2 Indeed, an international survey of 19 urologic
laparoscopic centers performing a total of 18,750 laparoscopic
procedures for urologic malignancies found tumor seeding in
13 cases (0.1%).8 Furthermore, the majority of port-site re-
currences reported in this survey represented TCC, including
four cases of incidental TCC after simple nephrectomy and
FIG. 1. Preoperative CT demonstrating an incidental 4-cm
right renal mass.
FIG. 2. Surgical pathology section of the right kidney
showed clear-cell tumor cells with Fuhrman grade 3.
FIG. 3. Routine follow-up CT 5 months after robot-assisted
partial nephrectomy for renal-cell carcinoma revealed a
1.7 cm mass located on the anterior abdominal wall at the
previous camera-port site.
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three cases of TCC after nephroureterectomy for suspected
TCC. The remaining six cases included four laparoscopic
adrenalectomies for lung cancer metastasis and one case each
of laparoscopic pelvic lymphadenectomy for penile squa-
mous cancer and retroperitoneal lymph node dissection for
nonseminomatous germ-cell testicular cancer.8 Of note, this
review by Micali and coworkers8 identified no instances of
port-site recurrence in 2604 cases of laparoscopic radical ne-
phrectomy (LRN) for RCC.
Very few cases of port-site recurrences after laparoscopic
extirpative surgery for RCC have been reported. After the first
report of a solitary port-site recurrence by Fentie and associ-
ates11 in 2000, there have been only eight additional reports of
port-site tumor recurrence after laparoscopic radical or partial
nephrectomy (Table 1). We report a 10th case in which tumor
metastasis at a robotic port site developed 5 months after
uncomplicated RAPN for localized RCC.
For port-site tumor recurrence to occur, several conditions
must be present. There must be release of viable cancer cells
from the tumor. There must be a mechanism by which these
tumor cells are transported to the port site. Last, implantation
of the tumor cells at the port site and subsequent growth must
occur. It has been hypothesized that several factors may aid in
this process, namely (1) the biologic aggressiveness of the
tumor, (2) local wound factors, (3) host immune responses,
and (4) laparoscopic surgical techniques.4
Tumor aggressiveness as defined by stage and Fuhrman
grade may have a significant impact on port site and overall
incidence of tumor recurrence.22–24 Of note, three of the nine
previously reported cases of PSM after laparoscopic radical or
partial nephrectomy for RCC were associated with locally
advanced, stage T2 or higher tumors. Moreover, all cases of
port-site recurrence after laparoscopic extirpative surgery for
RCC that are described in the literature have been associated
with intermediate to high-grade tumors (Fuhrman grade 2 or
greater). Indeed, the first of these cases occurred in association
with a tumor displaying Fuhrman grade 4 histopathology
with sarcomatoid elements. The case we present represents a
port-site recurrence of an early-stage (T1N0M0), high-grade
(Fuhrman grade 3) tumor, reminiscent of the case reported by
Castillo and colleagues.17
Local wound factors may aid the implantation and prolif-
eration of tumor cells at a port site. It has been demonstrated
that cancer cells have high proliferation potential within
healing skin incisions or intestinal anastomosis.25 Tumor cells
may implant more successfully during early wound healing,
adhering to fibrin deposited at the site of surgical trauma as a
part of normal healing.26 Furthermore, the presence of growth
factors at the wound site may promote the survival and
propagation of these cancer cells. Perhaps the port-site inci-
sion is more conducive than the laparotomy incision for
tumor seeding, as some animal studies and anecdotal expe-
rience seem to imply.27 In light of these risks, repair of the
peritoneum at the trocar entry site may reduce the risk of
tumor implantation and subsequent recurrence.28
Depressed immune function may also contribute to tumor
recurrence and metastasis. Overall immune function is di-
minished in the perioperative period because of several
mediating factors, including anesthetic agents, opioids,
surgical trauma, blood transfusions, temperature changes,
pain, and psychological stress.29 In animal models, surgical
trauma has been shown to reduce natural killer cell activity
and promote tumor metastasis.29,30 Furthermore, Chueh
and coworkers31 reported a case of PSM after bilateral hand-
assisted laparoscopic nephroureterectomy for TCC in a renal
transplant patient, underscoring the role of immunosup-
pression in the development of PSM. Similarly, Yildrim and
FIG. 5. The abdominal wall
mass before and after
resection. (A) The mass was
located at the camera-port
site from a previous robot-
assisted partial nephrectomy
and could be well visualized





FIG. 4. Biopsy sample of the port-site mass stained strongly
for renal-cell carcinoma-immunoperoxidase.
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colleagues32 reported an unusual case of port metastasis in a
renal transplant patient who underwent uneventful lapa-
roscopic cholecystectomy for benign gallbladder disease
and subsequently received a diagnosis of adenocarcinoma of
the colon with isolated colon cancer metastasis at the chole-
cystectomy port site. The physical distance between the
surgical site and the unsuspected colon tumor, which the
authors note had not been manipulated at the time of chole-
cystectomy, only serves to emphasize the role of host immu-
nity in the development of PSM.
Interestingly, three of the previously reported cases of PSM
after laparoscopic extirpative surgery for RCC occurred in
patients who had compromised immune function because of
other medical conditions. One patient had chronic renal fail-
ure and one had alcoholic cirrhosis, both associated with
compromised immune function.33,34 A third patient had dia-
betes mellitus, a condition also resulting in depressed im-
munity. In the case presented here, the patient also had a
history of diabetes mellitus for 15 years and was currently
receiving a two-drug regimen.
Several factors related to laparoscopic surgical technique
have been implicated in contributing to port-site recurrence
after LRN. These include the use of pneumoperitoneum, tro-
car site contamination, organ and tumor morcellation, and the
method of specimen retrieval.
There is debate in the literature as to whether gas insufflation/
desufflation during laparoscopy has an effect on the dissem-
ination of tumor cells. Several studies have suggested that
CO2 insufflation does have an impact on the movement of
tumor cells within the peritoneal cavity and subsequent im-
plantation at port sites.35,36 Jones and coworkers37 noted a
three-fold incidence in PSM in a hamster model of tumor cell
suspension when pneumoperitoneum was compared with
the results of the laparotomy only group. Wittich and asso-
ciates38 found that aerosolization of tumor cells does occur
during CO2 laparoscopy, but that the number of intraperito-
neal tumor cells needed for metastases to occur by this
mechanism is extremely high. To address this, others have
suggested that gas leakage around the port sites leads to a
‘‘chimney effect.’’39 Per the chimney effect hypothesis, the
continued leakage of gas around and through the trocar re-
sults in a cumulative buildup of tumor cells at the port site,
thus promoting PSM. Tseng and coworkers40 demonstrated
that tissue trauma at trocar sites, combined with leakage of
CO2, led to enhanced tumor growth at these sites. Never-
theless, studies by Hubens and colleagues41 failed to confirm
these findings, and the role of the chimney effect remains
unclear.
Another hypothesis posits that CO2 itself stimulates
tumor growth either through a direct effect on tumor cells or
by interfering with local defense mechanisms. Jacobi and
associates42 compared the effect of CO2 and helium on colon
adenocarcinoma growth after 30 minutes of pneumoper-
itoneum. Abdominal wound tumors developed in a signifi-
cantly greater number of animals in the CO2 group when
compared with the helium and anesthesia control groups. In
another study, Jacobi and coworkers43 demonstrated that
subcutaneous tumor growth is stimulated by CO2 indepen-
dent of intraperitoneal pressure. Kuntz and colleagues44
suggested that because lower pH has a recognized negative
impact on local defense mechanisms, this could explain the
higher incidence of PSM during laparoscopy with CO2
compared with other gases. The hypothesis that CO2 stim-
ulates tumor growth, however, was refuted in a study by
Tsivian and associates45 that showed that CO2 pneumoper-
itoneum does not increase the invasive potential of tumor
cells. Others have also found that CO2 pneumoperitoneum is
not essential for the development for PSM.22,23 Further
studies to define the role of CO2 insufflation in port-site re-
currences are needed.
In addition to the potential effects of pneumoperitoneum
on the transfer of tumor cells, it has also been proposed that
malignant cells may be transferred from the tumor to the port
site by the aggressive manipulation of the tumor with laparo-
scopic instruments and the subsequent withdrawal and re-
insertion of these contaminated instruments. Hewett and
associates46 were the first to demonstrate this concept in a pig
model. In his study, Hewett determined that malignant cells
were rarely found in CO2 exhaust (1/30 port filters), but were
more readily cultured from port washings (2/10 ports) and
instrument washings (4/10 laparoscopic instruments). Other
studies corroborate this finding and conclude that the exfoli-
ation of tumor cells secondary to aggressive surgical manip-
ulation increases the risk of port site tumor seeding, while the
risk of port site recurrence decreases with increased laparo-
scopic experience.47–9 The importance of minimizing tumor
manipulation is underscored by Greco and colleagues’18 PSM
case in which specimen rupture occurred during laparoscopic
partial nephrectomy. Irrigating port sites with povidone-
iodine at the completion of the case may lower the risk of port-
site recurrence.50 Local application of cytotoxic agents, such
methotrexate and cyclophosphamide, has also been shown to
be effective.51,52
It is our practice to perform intact specimen extraction
within an entrapment bag in all cases of suspected renal
malignancy. The case of port-site recurrence reported by
Iwamura and coworkers13 occurred in a setting in which an
entrapment bag was not used, and the free specimen was
removed through an unprotected incision, perhaps contri-
buting to the risk of PSM. The case of RCC metastasis at the
hand port (used for specimen extraction) after hand-assisted
LRN reported by Chen and colleagues15 provides an
FIG. 6. Follow-up CT scan 3 months after resection of the
port-site mass demonstrated no disease recurrence.

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































additional example of PSM when an entrapment bag was not
used. The use of an entrapment sack for specimen retrieval to
minimize port-site contamination has now been widely
adopted.
Another method for extraction is specimen morcellation,
which leads to a more cosmetically appealing result than the
usual 7-cm incision necessary for intact specimen removal
and is performed at many centers. While some long-term
studies have shown specimen morcellation to be oncologi-
cally safe,52,53 the role of morcellation in the pathogenesis of
PSM remains controversial. A study by Urban and cowork-
ers54 found that intact entrapment sacks were impermeable
to tumor cells and even to bacteria. Of the 24 sacks tested,
however, 4 had pinhole perforations when morcellation of
pig kidneys was performed. Moreover, morcellation was
performed in three of the nine previously reported cases of
RCC PSM the role of specimen morcellation in the devel-
opment of port-site recurrence in these three cases can cer-
tainly not be excluded. In fact, Castilho and colleagues12
attributed their case of PSM to microperforations in the en-
trapment bag during morcellation and have since modified
their technique to open extraction. Of note, Castilho and
associates12 performed their specimen morcellation in a
plastic bag, which others have shown to be particularly
vulnerable to perforation. When used, specimen morcella-
tion should be performed with great care in an impermeable,
nylon-reinforced entrapment bag and under direct vision to
minimize the risk of tissue spillage and subsequent wound
contamination.
The factors that contribute to PSM likely also play a role in
postsurgical peritoneal carcinomatosis. Unlike PSM, intra-
abdominal metastasis of RCC can occur as a first presentation
of RCC, outside of the setting of surgical manipulation.55
Peritoneal carcinomatosis, however, has also been noted in
the setting of partial nephrectomy. In 2008, Masterson and
Russo19 reported two cases of peritoneal carcinomatosis, one
that occurred 2 years after hand-assisted partial nephrectomy
for RCC and another that occurred after laparoscopic cryo-
ablation for RCC. Ultimately, both patients in these cases re-
ceived extensive surgical resection. Although they did not
have details from the original surgery, the authors noted that
the pathology sample in the first case was fragmented, sug-
gestive of an intraoperative tumor violation. While surgical
factors could certainly play a major role in peritoneal carcino-
matosis, biologic factors should not be understated. Adreno-
cortical carcinomas, for instance, have very high rates of
peritoneal carcinomatosis (83%) after laparoscopic resection,
despite adherence to oncologic principles.56
Indeed, the importance of biologic factors likely plays a
very large role in PSM. Highshaw and associates,57 for ex-
ample, reported on a case in which a patient underwent LRN
for RCC, followed by resection of a sacral chordoma 6 weeks
later. Although the two surgeries had different sites of dis-
section and were completely discontinuous, the patient was
later found to have a sacral chordoma metastasis to one of the
laparoscopic ports used for LRN. Similarly, while it is unclear
the exact cause of PSM in our case, our experience underscores
the importance of factors outside of surgeon control. In our
case, the tumor was not violated, surgical margins had neg-
ative results, an entrapment bag was used, and the specimen
was removed intact. The occurrence of a PSM at the camera-
port site despite these precautions highlights the other factors
that contribute to PSM. Aerosolization caused by pneumo-
peritoneum, escaping air causing a chimney effect, and/or
seeding of tumor into liquid suspension could all have con-
tributed to transport of microscopic amounts of tumor to the
camera port. There, tumor cells were able to take root despite
irrigation of the wounds, perhaps because of a combination of
global and local factors. Ultimately, however, we were able to
manage the isolated PSM in this instance with a minimally
invasive approach.
Conclusion
The incidence of port-site recurrence after LRN is rare,
and its etiology is likely multifactorial. Several measures
can be taken to minimize the risk of PSM: (1) Rigorous
adherence to oncologic surgical techniques with minimal
handling of the tumor, (2) trocar fixation and avoidance of
gas leakage along the trocar tract, (3) intact extraction or
morcellation within an impermeable bag under direct vi-
sion, and (4) povidine-iodine irrigation of the laparoscopic
instruments and port-site wounds when appropriate. Al-
though improper technique involving specimen manipula-
tion and extraction has been implicated in the etiology of
PSM, the current occurrence of PSM at the camera-port site
underscores the importance of tumor and wound-related
factors, host immunity, and other technical considerations in
the etiology of PSM.
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LRN¼ laparoscopic radical nephrectomy
PSM¼port site metastasis
RAPN¼ robot-assisted partial nephrectomy
RCC¼ renal-cell carcinoma
TCC¼ transitional-cell carcinoma
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